Last updated
Revenue
R&D Expenses
Operating CF
Total Assets
Total Liabilities
Equity
Shares Out.
D/E Ratio
Dilution Watch
Financials
52W LOW $1,023.0552W HIGH $1,728.66
Volume
189.46 K
Value Traded
212.70 M
Short % Float
3.31%
Days to Cover
3.1
+0.31%Week
+13.07%1 Month
+15.9%3 Month
+32.86%6 Month
-13.75%5 Year
+7,744.2%All Time
Cash Data
- Monthly Burn
- Burn Trend
- Dilution Risk
- SEC Filing
Key Stats
Market Cap
33.56 B
EPS (TTM)
45.20
P/E Ratio
37.05
Ent. Value
35.55 B
Total Shares
20.04 M
Float Shares
19.89 M
Insiders
0.74%
Institutions
105.93%
Upcoming Catalysts
FDA decisions, readouts and PDUFA dates · scored by probability of approval
| Catalyst | Drug / Treatment | Stage | Prob. of Approval | Description | Drug Type | Therapeutic Area | Source |
|---|---|---|---|---|---|---|---|
PDUFA 2026 | Example Drug Treatment for example condition requiring FDA review | Phase 3 | Small Molecule | Oncology | - |
PoA blends historical approval base rates, trial design score and FDA review track record.
MTD Catalyst Timeline
Dated clinical, regulatory and corporate events for Mettler-Toledo International, Inc.
Past FDA Catalysts and PDUFA Decisions
How MTD actually traded into and out of each decision
| Date | Drug | Catalyst | Stage | Reaction | Event Move % | Best Trade % |
|---|---|---|---|---|---|---|
| - | Example Drug | Phase 3 data readout | Phase 3 |
Reaction: 30 trading days around the event · Event Move: close to close on decision day · Best Trade: peak run-up from entry 10 days before the decision
Drug Pipeline Intelligence
No drug pipeline
Mettler-Toledo International, Inc. is a diagnostics company. The clinical trials it takes part in test other companies' drugs, so it has no drug pipeline of its own to score.
Clinical Trial Results
Readouts, endpoints and source filings for every MTD program
Inside Trades
| Insider | Side | Shares | Price | Value | Date |
|---|---|---|---|---|---|
| Kaltenbach PatrickOfficer (President and CEO) | Option | 942 5,422 held | $1,024.55 | 08/27/2026 |
Hedge Fund 13F Activity
Hedge Funds invested in MTD
| Fund | % of Portfolio | Current MV | Shares Owned | Activity |
|---|---|---|---|---|
| PFM HEALTH SCIENCES, LP | 1.5 % | 17.05 M | 13.34 K |
MTD Institutional Ownership Trends
MTD Short Interest
Shares sold short, counted twice a month.
3.31%
Short % of Float
of tradable shares sold short
657.7K
Shares Sold Short
-7.2% vs prior count
3.1 Moderate
Days to Cover
trading days of normal volume to buy every short share back
210.4K
Avg Daily Volume
the average used for days to cover
Options Data
Option Volume
Open Interest
Call OI
Put OI
Put-Call Ratio
OI 30-day avg
Today vs avg
Option Volume
Call Vol
Put Vol
Put-Call Ratio
Vol 30-day avg
Today vs avg
Option Chain Statistics
| Expiry | Call Vol | Put Vol | Vol P/C | Call OI | Put OI | OI P/C | IV Call | IV Call OI-Wtd | IV Call Vol-Wtd | IV Put | IV Put OI-Wtd | IV Put Vol-Wtd |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-11-20 | ||||||||||||
Real-Time Option Chain
| Calls | Strike | Puts | ||||
|---|---|---|---|---|---|---|
| Last | Vol | OI | Last | Vol | OI | |
| No data available | ||||||
Calls vs Puts by Expiry
CallsPutsLog scale
Competitive positioning
How MTD ranks across every disease it competes in
Competitive Position is a premium feature
See how MTD ranks against every competitor across each disease it develops in: phase, best drug, trials and likelihood of approval.
Start free trialMTD News
MTD▼ -2.5%today
Mettler-Toledo International Inc. to Present at Upcoming Investor Conferences
Mettler-Toledo International Inc. will present at the UBS Global Healthcare Conference on November 11 and the Stifel 2026 Healthcare Conference on November 12. The company is recognized for its leadership in precision instruments and has a strong market presence in various industries, including life sciences and food. Live webcasts of the presentations will be available on their investor relations website.
Read more →MTDMettler-Toledo International Inc. to Host Investor Meeting
Mettler-Toledo International Inc. will host an investor meeting on November 9, starting at 8:45 a.m. Eastern Time. The meeting will include a public webcast accessible via the company's website. Mettler-Toledo is recognized for its leadership in precision instruments and services across various industries.
Read more →MTDMettler-Toledo International Inc. to Host Third Quarter 2026 Earnings Conference Call
Mettler-Toledo International Inc. will release its third quarter 2026 financial results on November 5, 2026. A conference call is scheduled for the following morning at 8:30 a.m. Eastern Time to discuss these results. The company emphasizes its leadership in precision instruments across various industries.
Read more →MTDNatalia Shuman Joins METTLER TOLEDO Board of Directors
Mettler-Toledo International Inc. announced the appointment of Natalia Shuman to its Board of Directors, effective August 3, 2026. Shuman, currently the CEO of MISTRAS Group, has extensive experience in leadership roles across various industries. Her expertise in technology and digital enablement is expected to benefit the company significantly.
Read more →MTDMettler-Toledo International Inc. Reports Second Quarter 2026 Results
Mettler-Toledo International Inc. reported a 4% increase in sales for Q2 2026, totaling $1.027 billion. Adjusted EPS grew by 14% to $11.46, driven by strong organic sales growth, particularly in China and emerging markets. Management expects local currency sales to rise approximately 4% in Q3 2026, with adjusted EPS forecasted between $12.00 and $12.15.
Read more →MTDMettler-Toledo International Inc. to Host Second Quarter 2026 Earnings Conference Call
Mettler-Toledo International Inc. will release its second quarter 2026 financial results on July 30, 2026. A conference call is scheduled for the following morning at 7:30 a.m. Eastern Time to discuss these results. The company is a leading supplier of precision instruments and has a strong market presence globally.
Read more →MTDMETTLER-TOLEDO INTERNATIONAL INC. REPORTS FIRST QUARTER 2025 RESULTS
Mettler-Toledo International Inc. reported its first-quarter results for 2026, showing a 7% increase in reported sales compared to the previous year, totaling $947.1 million. Adjusted EPS also saw a rise, reaching $8.91, indicating solid financial performance despite an uncertain market environment. The company forecasts continued growth in local currency sales and adjusted EPS for the upcoming quarters, highlighting confidence in its strategic initiatives. However, management noted potential uncertainties due to market conditions and geopolitical influences.
Read more →MTDMettler-Toledo International Inc. Announces Webcast of Presentation at the BofA Securities 2026 Healthcare Conference
Mettler-Toledo International Inc. will present at the BofA Securities 2026 Healthcare Conference on May 13, 2026, at 8:00 a.m. PT. A live webcast of the presentation will be accessible on the company's investor relations website. Mettler-Toledo is recognized as a leader in precision instruments and services across various industries.
Read more →MTDMettler-Toledo International Inc. to Host First Quarter 2026 Earnings Conference Call
Mettler-Toledo International Inc. will release its Q1 2026 financial results on May 7, 2026. A conference call will follow on May 8 at 8:30 a.m. ET to discuss the results. The company is a leading global supplier of precision instruments, recognized for its innovation and strong market positions.
Read more →MTDMETTLER-TOLEDO INTERNATIONAL INC. REPORTS FOURTH QUARTER 2025 RESULTS
Mettler-Toledo International Inc. reported a strong fourth quarter for 2025, with sales rising 8% year-over-year to reach $1.130 billion. The company's adjusted earnings per share increased to $13.36, reflecting robust financial performance amid challenging market conditions. Management anticipates continued growth, with forecasts indicating a 3% increase in local currency sales for Q1 2026 and an expected adjusted EPS growth of 8% to 9% for the full year. The leadership emphasized resilience and agility in navigating global trade disputes and soft market conditions.
Read more →MTDMETTLER TOLEDO Announces Michael J. Tokich to Join Board of Directors
Mettler-Toledo International Inc. appointed Michael J. Tokich to its Board of Directors, effective February 5, 2026. Tokich, who previously served as CFO at STERIS plc, brings nearly two decades of public company experience. His financial and operational insights are expected to benefit Mettler-Toledo's strategic initiatives.
Read more →MTDMETTLER-TOLEDO INTERNATIONAL INC. REPORTS THIRD QUARTER 2025 RESULTS
Mettler-Toledo International Inc. reported its third-quarter results for 2025, showcasing an 8% increase in reported sales compared to the prior year. The net earnings per diluted share grew to $10.57, and adjusted EPS saw a 9% rise to $11.15. Although management anticipates solid growth moving forward, including a projected local currency sales growth of 4% for 2026, they also highlighted potential challenges such as tariff costs and uncertainties in global trade. An additional $2.75 billion was authorized for share repurchase, emphasizing the company's strong financial position.
Read more →MTDMETTLER-TOLEDO INTERNATIONAL INC. REPORTS SECOND QUARTER 2025 RESULTS
Mettler-Toledo International Inc. reported second quarter 2025 results with a 4% increase in reported sales compared to the previous year. The company recorded an adjusted EPS of $10.09, marking a 5% increase from last year's amount. However, net earnings per diluted share decreased from $10.37 to $9.76. Management expressed cautious optimism about future sales growth, anticipating a slight increase despite uncertainties such as tariff costs and trade disputes impacting the market.
Read more →MTDMETTLER-TOLEDO INTERNATIONAL INC. REPORTS THIRD QUARTER 2024 RESULTS COLUMBUS, Ohio, USA
Mettler-Toledo International Inc. reported its third quarter results for 2024, highlighting a 1% increase in total reported sales year-over-year and a notably strong adjusted EPS of $10.21. The company experienced robust growth in its Laboratory business and services, yet indicated that market conditions, especially in the Industrial sector, remain challenging. Despite some regional declines, particularly in Asia, the management anticipates sales growth in the upcoming quarter, bolstered by previous shipping delays. Furthermore, the company has introduced several innovations aimed at enhancing growth opportunities.
Read more →MTDMETTLER-TOLEDO INTERNATIONAL INC. REPORTS SECOND QUARTER 2024 RESULTS COLUMBUS, Ohio, USA
Mettler-Toledo International Inc. reported its second-quarter results for 2024, reflecting a 4% decline in reported sales year-over-year to $946.8 million. Despite this decline, the company demonstrated an increase in net earnings per share to $10.37, boosted by a one-time tax benefit. Sales increased in Europe and the Americas, but saw significant drops in the Asia region due to weak market conditions. Management projects modest growth in local currency sales for the upcoming quarters, emphasizing continued productivity and margin improvements amidst challenging conditions.
Read more →MTDBRIAN SHEPHERD JOINS METTLER TOLEDO BOARD OF DIRECTORS COLUMBUS, Ohio, USA
Mettler-Toledo International Inc. has appointed Brian Shepherd to its Board of Directors. Shepherd most recently served as Senior Vice President at Rockwell Automation and has significant leadership experience in the industrial automation sector. His background in data analytics and software solutions is expected to enhance Mettler Toledo's strategic growth in these areas. The company views this appointment as a step towards advancing its capabilities in the Smart Factory domain.
Read more →MTDMETTLER-TOLEDO INTERNATIONAL INC. REPORTS FIRST QUARTER 2024 RESULTS COLUMBUS, Ohio, USA
Mettler-Toledo International Inc. reported its first quarter 2024 results, showing flat sales at $925.9 million compared to the prior year, with a modest 2% increase in adjusted EPS. Despite recovering delayed shipments from the previous quarter, the company faced reduced market demand, particularly in China. Management forecasts a decline in local currency sales for the upcoming second quarter and warns of potential headwinds due to adverse currency impacts. Overall, the company remains focused on growth strategies and innovation.
Read more →MTDMETTLER-TOLEDO INTERNATIONAL INC. REPORTS FOURTH QUARTER 2023 RESULTS COLUMBUS, Ohio, USA
Mettler-Toledo International Inc. reported its fourth-quarter results for 2023, revealing a 12% decline in sales compared to the prior year, largely due to shipping delays. Adjusted earnings per share (EPS) also fell by 22%, with ineffective logistics from a European provider cited as a key factor. Despite these declines, the company anticipates a recovery in sales in the upcoming quarter and remains committed to cost control and innovation. The management forecasts mixed results for the first quarter of 2024, emphasizing the need to stay adaptable in a challenging market environment.
Read more →About Mettler-Toledo International, Inc.
Headquarters1900 POLARIS PARKWAY, COLUMBUS, OH, 43240
BIOPHARMAWATCH ELITE PLUS
Trade the next MTD catalyst before the market reprices
Every FDA decision, PoA score, 13F move and dilution flag on this page, for 1,100+ biotech tickers. From $19/mo billed annually.
Cancel anytime